Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Circ Heart Fail. 2016 Feb;9(2):e002206. doi: 10.1161/CIRCHEARTFAILURE.115.002206

Table 3.

Histomorphometric findings at the end of 3 months in normal dogs (n=7), in untreated heart failure control dogs (HF-CON) (n=7) and in heart failure dogs treated with elamipretide (HF+ELA) (n=7).

VFRF (%) VFIF (%) CD (cap/mm2) ODD (μm) MCSA (μm2)
Normal 0.0 3.7±0.07 2609±79.5 8.9±0.17 410±10.0
HF-CON 12.3±0.6* 11.8±0.5* 1806±80* 12.6±0.2* 678±5.4*
HF+ELA 11.2±0.9 9.7±0.5 2026±127 11.4±0.4 600±4.3

Data are shown as Mean ± SEM. VFIF=volume fraction of interstitial fibrosis; VFRF=volume fraction of replacement fibrosis; CD=capillary density; ODD=oxygen diffusion distance; MCSA=myocyte cross-sectional area. All data are Mean±SEM.

*

p<0.05 vs. Normal,

p<0.05 vs. HF-CON.